Sichuan Kelun Pharmaceutical Hits Day High with 7.93% Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.93% on March 6, 2026. The stock reached an intraday high of CNY 32.84, marking a notable achievement for the company within the pharmaceuticals and biotechnology sector. In terms of performance metrics, Sichuan Kelun has shown a 1-day performance that outpaces the China Shanghai Composite, which recorded a modest increase of 0.38%. Over the past week, the stock has risen by 7.01%, contrasting with a decline of 0.93% in the broader market. Year-to-date, the company has achieved an 11.35% increase, significantly outperforming the China Shanghai Composite's 3.91% gain. Despite these short-term gains, the company has faced challenges, including a decline in net sales of 15.48% reported in September. Additionally, the stock has underperformed over the past year, generating a return of 5.59% compared to the market's 21.98%. With a market capitalization of CNY 36,978 million, Sichuan Kelun continues to navigate a complex financial landscape while achieving notable intraday highs.